Diagnosis and Treatment of Lupus Nephritis: Survey Results on Four Important Issues
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 주영빈 | - |
dc.contributor.author | 성윤경 | - |
dc.contributor.author | 박용범 | - |
dc.contributor.author | 서창희 | - |
dc.contributor.author | 심승철 | - |
dc.contributor.author | 이영호 | - |
dc.contributor.author | 이지수 | - |
dc.contributor.author | 이혜순 | - |
dc.contributor.author | 차훈석 | - |
dc.contributor.author | 배상철 | - |
dc.date.accessioned | 2021-09-06T06:08:07Z | - |
dc.date.available | 2021-09-06T06:08:07Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2093-940X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/104477 | - |
dc.description.abstract | Objectives. To investigate the perception of and treatment pattern with regard to the four important issues in the management of lupus nephritis (LN), and to identify which parts of the LN treatment are difficult for physicians to carry out in clinical practice. Methods. Four steps were carried out: pre-survey, LN symposium, post-survey, and meeting after the symposium.The two surveys were conducted with the same contents regarding renal biopsy, induction and maintenance treatment for class III and IV LN, and treatment for class V LN. The results of the first survey and the changes in opinion reflected in the second survey were comparatively analyzed. Results. In the first survey, most of the respondent physicians replied that they would immediately conduct biopsy in the case of significant proteinuria. For the induction treatment of class III and IV LN, most of the respondent physicians selected high-dose cyclophosphamide. Mycophenolate mofetil and steroid combination therapy were selected for the maintenance treatment, and tacrolimus for the treatment of class V LN. There was a controversy in the drug selection, however, especially on the maintenance treatment of class III and IV LN and on the treatment of non-responsive class V LN. Conclusion. Some discrepancies were found in the treatment of LN in the real world. Although no recommendation was made for Korean LN patients in this study, the study results will help physicians select the most reasonable treatment for Korean LN patients based on experts’ experiences and objective evidence. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | 대한류마티스학회 | - |
dc.title | Diagnosis and Treatment of Lupus Nephritis: Survey Results on Four Important Issues | - |
dc.title.alternative | Diagnosis and Treatment of Lupus Nephritis: Survey Results on Four Important Issues | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 이영호 | - |
dc.identifier.bibliographicCitation | 대한류마티스학회지, v.20, no.3, pp.156 - 165 | - |
dc.relation.isPartOf | 대한류마티스학회지 | - |
dc.citation.title | 대한류마티스학회지 | - |
dc.citation.volume | 20 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 156 | - |
dc.citation.endPage | 165 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001787170 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Lupus nephritis | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordAuthor | Guideline | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.